Fragasso Group Inc. Merck & Co., Inc. Transaction History

Fragasso Group Inc.

  • $1.14 Billion
  • Q1 2025

A detailed history of Fragasso Group Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 11,604 shares of MRK stock, worth $891,651. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,604
Previous 42,933 72.97%
Holding current value
$891,651
Previous $4.27 Million 75.62%
% of portfolio
0.09%
Previous 0.34%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 09, 2025
SELL
$83.01 - $101.02 $2.6 Million - $3.16 Million
-31,329 Reduced 72.97%
11,604 $1.04 Million
Q4 2024

Jan 13, 2025
SELL
$96.31 - $114.76 $1.04 Million - $1.24 Million
-10,769 Reduced 20.05%
42,933 $4.27 Million
Q3 2024

Oct 07, 2024
BUY
$111.15 - $128.97 $340,452 - $395,035
3,063 Added 6.05%
53,702 $6.1 Million
Q2 2024

Jul 08, 2024
SELL
$123.8 - $132.96 $391,703 - $420,685
-3,164 Reduced 5.88%
50,639 $6.27 Million
Q1 2024

Apr 10, 2024
SELL
$113.24 - $131.95 $150,609 - $175,493
-1,330 Reduced 2.41%
53,803 $7.1 Million
Q4 2023

Jan 08, 2024
BUY
$100.18 - $109.02 $587,154 - $638,966
5,861 Added 11.9%
55,133 $6.01 Million
Q3 2023

Dec 06, 2023
BUY
$102.95 - $114.33 $395,842 - $439,598
3,845 Added 8.46%
49,272 $5.07 Million
Q2 2023

Jul 10, 2023
BUY
$108.61 - $118.38 $2.86 Million - $3.11 Million
26,307 Added 137.59%
45,427 $5.24 Million
Q1 2023

Apr 13, 2023
BUY
$102.94 - $114.86 $12,867 - $14,357
125 Added 0.66%
19,120 $2.03 Million
Q4 2022

Jan 24, 2023
SELL
$87.44 - $112.11 $1.66 Million - $2.13 Million
-18,995 Closed
0 $0
Q4 2022

Jan 24, 2023
SELL
$87.44 - $112.11 $3,235 - $4,148
-37 Reduced 0.19%
18,995 $0
Q3 2022

Oct 13, 2022
BUY
$84.53 - $94.96 $3,381 - $3,798
40 Added 0.21%
19,032 $1.64 Million
Q2 2022

Aug 30, 2022
BUY
$83.49 - $94.64 $1.07 Million - $1.21 Million
12,781 Added 205.78%
18,992 $1.73 Million
Q1 2022

Apr 06, 2022
BUY
$73.51 - $82.4 $1,617 - $1,812
22 Added 0.36%
6,211 $510,000
Q4 2021

Jan 19, 2022
SELL
$72.28 - $90.54 $6,938 - $8,691
-96 Reduced 1.53%
6,189 $474,000
Q3 2021

Oct 08, 2021
SELL
$71.68 - $78.83 $8,816 - $9,696
-123 Reduced 1.92%
6,285 $472,000
Q2 2021

Jul 19, 2021
BUY
$70.31 - $77.77 $6,679 - $7,388
95 Added 1.5%
6,408 $498,000
Q1 2021

May 27, 2021
BUY
$68.86 - $81.11 $10,879 - $12,815
158 Added 2.57%
6,313 $487,000
Q4 2020

Feb 04, 2021
BUY
$71.77 - $79.65 $1,291 - $1,433
18 Added 0.29%
6,155 $504,000
Q2 2020

Aug 10, 2020
SELL
$70.42 - $80.13 $172,036 - $195,757
-2,443 Reduced 28.47%
6,137 $497,000
Q1 2020

May 14, 2020
SELL
$63.36 - $87.82 $36,875 - $51,111
-582 Reduced 6.35%
8,580 $660,000
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $198,992 - $224,540
2,565 Added 38.88%
9,162 $833,000
Q3 2019

Nov 13, 2019
SELL
$76.08 - $82.93 $7,531 - $8,210
-99 Reduced 1.48%
6,597 $555,000
Q2 2019

Aug 13, 2019
BUY
$69.84 - $81.59 $29,961 - $35,002
429 Added 6.85%
6,696 $561,000
Q1 2019

May 08, 2019
SELL
$69.58 - $79.36 $17,464 - $19,919
-251 Reduced 3.85%
6,267 $521,000
Q4 2018

Feb 12, 2019
BUY
$65.24 - $75.71 $20,485 - $23,772
314 Added 5.06%
6,518 $498,000
Q3 2018

Nov 13, 2018
SELL
$57.69 - $67.84 $8,595 - $10,108
-149 Reduced 2.35%
6,204 $463,000
Q2 2018

Aug 01, 2018
BUY
$50.83 - $59.72 $24,805 - $29,143
488 Added 8.32%
6,353 $386,000
Q1 2018

May 14, 2018
SELL
$50.96 - $59.23 $108,035 - $125,567
-2,120 Reduced 26.55%
5,865 $319,000
Q4 2017

Feb 09, 2018
SELL
$51.62 - $61.64 $9,807 - $11,711
-190 Reduced 2.32%
7,985 $449,000
Q3 2017

Nov 13, 2017
BUY
$58.67 - $63.13 $479,627 - $516,087
8,175
8,175 $523,000

Others Institutions Holding MRK

# of Institutions
3,894
Shares Held
1.93B
Call Options Held
26.2M
Put Options Held
23.5M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $195B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email